BILIBABY Trademark

Trademark Overview

On Tuesday, April 18, 2023, a trademark application was filed for BILIBABY with the United States Patent and Trademark Office. The USPTO has given the BILIBABY trademark a serial number of 97893254. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, December 18, 2024. This trademark is owned by Bilibaby, LLC. The BILIBABY trademark is filed in the Medical Instrument Products category with the following description:

Non-invasive medical devices, namely, medical instruments for non-invasive measurement and analysis of bilirubin, bodily fluids, body products, drugs and biologics marked for color markers, and drugs and biologics containing color markers

General Information

Serial Number97893254
Word MarkBILIBABY
Filing DateTuesday, April 18, 2023
Status680 - APPROVED FOR PUBLICATION
Status DateWednesday, December 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesNon-invasive medical devices, namely, medical instruments for non-invasive measurement and analysis of bilirubin, bodily fluids, body products, drugs and biologics marked for color markers, and drugs and biologics containing color markers

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, May 12, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBilibaby, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPhoenixville, PA 19460

Trademark Events

Event DateEvent Description
Friday, April 21, 2023NEW APPLICATION ENTERED
Friday, May 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 16, 2024ASSIGNED TO EXAMINER
Thursday, January 18, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, January 18, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, January 18, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 18, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, February 8, 2024NON-FINAL ACTION WRITTEN
Thursday, February 8, 2024NON-FINAL ACTION E-MAILED
Thursday, February 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 7, 2024FINAL REFUSAL WRITTEN
Friday, June 7, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, June 7, 2024FINAL REFUSAL E-MAILED
Friday, September 6, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, November 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 26, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, November 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 6, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Related Keywords

bilibaby drugs invasive biologics color medical markers products marked containing body